Obdulia Rabal

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 9

Top Topics

Fluorescence Imaging

Cognitive Decline

Histone Deacetylase

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

Journal of computer-aided molecular design

Journal of cheminformatics

This page only lists publications with an associated author ORCID identifier.

Publications

Emilie Pihan, Martin Kotev, Obdulia Rabal, Claudia Beato, Constantino Diaz Gonzalez
Fine tuning for success in structure-based virtual screening. Journal of computer-aided molecular design 35 (12) (2021)
Edgar López-López, Obdulia Rabal, Julen Oyarzábal, José Luis Medina-Franco
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach. Journal of computer-aided molecular design 34 (6) (2020)
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Haizhong Tan, Wei Wu, Musheng Xu, Antonio Pineda-Lucena, Ana Garcia-Osta, Julen Oyarzábal
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles. ACS chemical neuroscience 10 (9) (2019)
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Amaia Vilas-Zornoza, Ana Ugarte, Irene de Miguel, Estíbaliz Miranda, Leire Garate, Mario Fraga, Pablo Santamarina, Raul Fernandez Perez, Raquel Ordoñez, Elena Sáez, Sergio Roa, María José García-Barchino, José Angel Martínez-Climent, Yingying Liu, Wei Wu, Musheng Xu, Felipe Prosper, Julen Oyarzábal
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy. Journal of medicinal chemistry 61 (15) (2018)
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Tan Haizhong, Wu Wei, Xu Musheng, Ana Garcia-Osta, Julen Oyarzábal
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors. ACS chemical neuroscience 10 (3) (2018)
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, Xabier Agirre, Irene de Miguel, Leire Garate, Estibaliz Miranda, Elena Sáez, Sergio Roa, José Angel Martínez-Climent, Yingying Liu, Wei Wu, Musheng Xu, Felipe Prosper, Julen Oyarzábal
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces. Journal of medicinal chemistry 61 (15) (2018)
Javier Vázquez, Alessandro Deplano, Albert Herrero, Tiziana Ginex, Enric Gibert, Obdulia Rabal, Julen Oyarzábal, Enric Herrero, Francisco Javier Luque
Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen. Journal of chemical information and modeling 58 (8) (2018)
Obdulia Rabal, Andrea Castellar, Julen Oyarzabal
Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization. Journal of cheminformatics 10 (1) (2018)
Martin Krallinger, Obdulia Rabal, Anália Lourenço, Julen Oyarzábal, Alfonso Valencia
Information Retrieval and Text Mining Technologies for Chemistry. Chemical reviews 117 (12) (2017)